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It is clearly more effi cient for us to update ourselves through 
good sources of evidence than to try to keep track of the roughly 
two million articles that are published in the fi eld of healthcare 
every year. 
Excellent sources of evidence do exist, as our readers are 
already tired of hearing about. This will increasingly be the role 
of good medical journals. Just so that we do not lose the habit, 
we will again recommend here the Cochrane Library (http://co-
chrane.bvsalud.org/), ACP Journal Club (http://www.acpjc.org/) 
and the Bulletin of the Agency for Healthcare Research and 
Quality (AHRQ) of the U.S. Department of Health and Human 
Services (http://www.ahrq.gov/research/resact.htm).
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Worldwide, well-prepared health ministries are in the habit 
of ordering systematic reviews and evidence-based healthcare 
technology assessments from specifi c centers, generally based 
on reviews using the Cochrane methodology. The Brazilian 
Ministry of Health, through its Department of Technological 
Assessment, recently received 27 reviews (Table 1) that had 
been prepared by teams at the Brazilian Cochrane Center. Some 
of them made it possible to prevent expenditure of around 
R$1.2 billion over the three years preceding the publication 
of the results by the Cochrane Library and in a major journal, 
which were shown to be the same as those prepared by the 
team at the Brazilian Cochrane Center.1
Table 1. List of reviews prepared by teams at the Brazilian Cochrane Center for the Ministry of Health
01. Acupuncture for headache
02. Acupuncture for lateral epicondylitis
03. Acupuncture for low back pain
04. Acupuncture for carpal tunnel syndrome
05. Adalimumab for treating rheumatoid arthritis
06. Ferrara’s ring for treating keratoconus
07. Intragastric balloons for obese individuals
08. Reused versus new electrophysiology catheters
09. Roux-en-Y gastric derivation for surgically treating morbid obesity
10. Drotrecogin for treating severe sepsis
11. Efalizumab for treating psoriasis
12. Embolization for treating uterine myoma
13. Comparative study on treatments for Parkinson’s disease: deep cerebral stimulation using electrodes versus neuroablative procedures
14. Imatinib for chronic myeloid leukemia
15. Imatinib for treating gastrointestinal tumors
16. Skin replacement materials for treating burns
17. Nucleoplasty for treating disc hernias
18. Suburethral suspension operations for urinary incontinence in women
19. Stents covered with rapamycin or paclitaxel versus conventional stents
20. Mechanical suture versus manual suture in colorectal anastomoses
21. Intersomatic fusion techniques at single or double intervertebral level for treating cervical degenerative disc disease
22. Surgical treatment techniques for morbid obesity: Mason bands/gastroplasty
23. Surgical treatment techniques for morbid obesity: duodenal switch/Scopinaro
24. Photodynamic therapy for age-related neovascular macular degeneration
25. Teriparatide [recombinant human parathyroid hormone (1-34)] for treating osteoporosis in postmenopausal women
26. Cardiac resynchronization therapy: use of multisite pacemaker
27. Surgical treatments for epilepsy
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An article prepared at the request of the 
AHRQ, by Duke University’s Evidence-Based 
Practice Center, showed on a large sample of 
15,000 cases that, in treating arterial hyper-
tension, the effects of angiotensin-converting 
enzyme (ACE) inhibitors and angiotensin 
receptor inhibitors were very similar in clini-
cal practice. The only difference found was in 
the prevalence of coughing: 1.7% of the 
patients who received ACE inhibitors versus 
0.6% of those who received angiotensin recep-
tor inhibitors. This report is available in full 
on the website http://effectivehealthcare.ahrq.
gov/index.cfm.2
Even more interesting is an article pub-
lished in the Archives of Pediatric and Ado-
lescent Medicine, which showed that in the 
United States, Latinos hardly ever drink tap 
water and do not give tap water to their chil-
dren. They almost always used bottled mineral 
water, like in Brazil.3 This takes away from 
their children the fluoride that is added to tap 
water and compromises the oral health of the 
population, if the fluoride is not adequately 
supplemented. The most interesting point in 
this is that the quality requirements for tap 
water are higher than are those for bottled 
mineral water. The situation is not expected to 
be any different in Brazil. In clinical practice, 
we have seen cases of diarrhea relating to water 
described as mineral water that is delivered to 
homes. And I ask: is there any proof of quality 
control over water sold in Brazil?
By carrying out a search using the terms 
“fluoride” and “boiled water” in databases like 
the Latin-American and Caribbean Health 
Sciences Literature (Literatura Latino-ameri-
cana e do Caribe em Ciências da Saúde, Lilacs), 
Brazilian Dental Bibliography (Bibliografia 
Brasileira de Odontolologia, BBO) and Scirus, 
we find evidence that boiling tap water main-
tains or increases the fluoride concentration, 
which may be a good solution.4,5
One further point of great interest: the 
AHRQ has just released a DVD on how to 
build hospitals (or how to refurbish them, 
which is our eternal problem), to assist ar-
chitects, engineers and physicians to build 
hospitals in which the plans incorporate prin-
ciples of evidence-based hospital architecture.6
This is available on the website http://www.
ahrq.gov/qual/transform.htm. We are get-
ting there. 
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